China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
Moderna stock jumped early Tuesday after the first bird-flu death was reported in the U.S.Shares were up 3.3% to $43.98 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback